Berberine Mitigates Betel-Nut Induced Hepatocarcinogenesis, Enhances Chemosensitivity to Cisplatin and Reduces Cisplatin- Induced Nephrotoxicity in Mice Exposed to an Aqueous Extract of Betel Nut
Authors:
- Kasturi BhattacharjeeKBKasturi Bhattacharjee
- Moumita NathMNMoumita Nath
- Yashmin ChoudhuryYCYashmin Choudhury
Open Access
- 1 November 2024
- journal article
- Published by Manuscript Technomedia LLP in Pharmacognosy Journal
- Vol. 16 (5) , 1021-1028
Abstract
Background: There is a considerable correlation between the use of betel-nut (BN) as a chewing substance and the development of various malignancies. Objective: The bioactive phytocompound berberine was tested as monotherapy or in combination with cisplatin to reduce BN-induced carcinogenesis in mice. We also examined how berberine affected cisplatin-induced toxicity. Methods: Swiss Albino mice were exposed to aqueous extract of betel-nut (AEBN) at a dose of 2 mg ml-1 in drinking water, for 16 weeks. Following this, the mice were given a combination of AEBN and berberine (10 mg kg-1) for 8 weeks. Control mice were given drinking water without AEBN for 24 weeks. For the combination treatment, mice that had been exposed to AEBN (2 mg ml-1) for 16 weeks were given AEBN+sodiumchloride+cisplatin (5 mg kg-1) +berberine (10 mg kg-1) for 2 weeks. Histopathology, oxidative stress, proliferation, apoptosis, oncogenic and tumor suppressor proteins, hepatotoxicity, and nephrotoxicity were assessed in tissues retrieved at treatment endpoints. Results: Berberine monotherapy reduced tissue dysplasia, liver nodulation, oxidative stress, proliferation (Ki-67 and Cyclin D1) markers, Akt/mTOR signaling, and pP53 (Ser-15) levels and apoptosis in AEBN-treated mice to levels comparable to cisplatin alone. Berberine with cisplatin decreased nephrotoxicity, fur shedding, and cancer phenotype more than cisplatin alone. Conclusion: The study results imparted a new therapeutic approach in developing more effective and less harmful cancer treatments.Keywords
This publication has 23 references indexed in Scilit:
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeuticsGenes & Diseases, 2022
- Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapiesPhytotherapy Research, 2021
- Vildagliptin, a dipeptidyl peptidase-4 inhibitor, reduces betel-nut induced carcinogenesis in female miceLife Sciences, 2021
- Pretreatment with berberine protects against cisplatin-induced renal injury in male Wistar ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Treatment with the anti-diabetic drug metformin ameliorates betel-nut induced carcinogenesis in a murine modelPharmacological Reports, 2019
- Cisplatin: The first metal based anticancer drugBioorganic Chemistry, 2019
- Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promotersNucleic Acids Research, 2014
- Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosisFood and Chemical Toxicology, 2013
- Dose–response of berberine on hepatic cytochromes P450 mRNA expression and activities in miceJournal of Ethnopharmacology, 2011
- Cyclin D1 Expression Mediated by Phosphatidylinositol 3-Kinase through mTOR-p70S6K-Independent Signaling in Growth Factor-Stimulated NIH 3T3 FibroblastsMolecular and Cellular Biology, 1999